Keep exploring. Keep fighting.
POMALYST with dexamethasone is proven to keep up the fight if MM stops responding to REVLIMID® (lenalidomide) and a proteasome inhibitor. It’s also:
- Proven to help patients live longer without their disease getting worse*
- An oral medication that can be taken wherever is convenient for you
*In a clinical trial with 455 patients, whose MM had stopped responding to at least 2 prior medicines, including REVLIMID and a proteasome inhibitor, median Progression-Free Survival for patients taking POMALYST with low-dose dexamethasone was 3.6 months. This was 2 times longer than the 1.8 months that patients lived without their disease getting worse when they were given high-dose dexamethasone alone. POMALYST may not work for everyone. Ask your doctor if POMALYST with dexamethasone is right for you.